Illumina, Inc. vs KraneShares CSI China Internet ETF — how do they compare? Illumina, Inc. trades at $264.24 (market cap $40.43B), while KraneShares CSI China Internet ETF trades at $24.5 (market cap $4.46B). The key difference: Illumina, Inc. is far larger — about 9.1× KraneShares CSI China Internet ETF's market cap, and Illumina, Inc. is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| ILMN | KWEB | |
|---|---|---|
Market Cap | $40.43B | $4.46B |
Volume | 2,948,626 | 11,090,451 |
Sector | Health | Sector/Thematic |
52-Week High | $293.69 | $41.35 |
52-Week Low | $91.00 | $23.63 |
Typical Hold Time | 83 Days | 57 Days |
Enterprise Value | $41.79B | — |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 3.34% on the day but up significantly year-to-date with strong technical momentum. The stock shows bullish moving average signals and trades near pivot point resistance at $268. Fundamentally, the company has delivered three consecutive quarterly earnings beats and returned to profitability in 2025 with $850 million net income after previous losses. Recent catalysts include S&P 500 inclusion effective September 21, 2026, and growing AI integration in genomics applications.
The outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI-driven biological data expansion, while risks involve China market headwinds and elevated valuation multiples. Earnings growth and S&P 500 inclusion provide near-term catalysts, but the stock trades at premium valuations with P/E of 49.96 requiring sustained execution.
KWEB trades at $24.33, down 0.86% with a bearish technical signal. Moving averages indicate selling pressure, while oscillators are neutral. Support and resistance cluster around $24-$25. Recent news highlights U.S.-China trade dynamics and institutional stake changes, with mixed sentiment on Chinese internet stocks amid economic rebalancing talks.
The outlook remains cautious due to geopolitical risks and weak technicals. Opportunities exist if trade tensions ease, but risks include Chinese regulatory shifts and global protectionism. Investor sentiment is divided, with some institutions reducing exposure while others accumulate, reflecting uncertainty in China's economic trajectory.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →